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Smooth Muscle Cells in Atherosclerosis Originate From the
Local Vessel Wall and Not Circulating Progenitor Cells in
ApoE Knockout Mice
Jacob F. Bentzon, Charlotte Weile, Claus S. Sondergaard, Johnny Hindkjaer,
Moustapha Kassem, Erling Falk
Objective—Recent studies of bone marrow (BM)-transplanted apoE knockout (apoE/) mice have concluded that a
substantial fraction of smooth muscle cells (SMCs) in atherosclerosis arise from circulating progenitor cells of
hematopoietic origin. This pathway, however, remains controversial. In the present study, we reexamined the origin of
plaque SMCs in apoE/ mice by a series of BM transplantations and in a novel model of atherosclerosis induced in
surgically transferred arterial segments.
Methods and Results—We analyzed plaques in lethally irradiated apoE/ mice reconstituted with sex-mismatched BM
cells from eGFPapoE/ mice, which ubiquitously express enhanced green fluorescent protein (eGFP), but did not find
a single SMC of donor BM origin among 10 000 SMC profiles analyzed. We then transplanted arterial segments
between eGFPapoE/ and apoE/ mice (isotransplantation except for the eGFP transgene) and induced atheroscle-
rosis focally within the graft by a recently invented collar technique. No eGFP SMCs were found in plaques that
developed in apoE/ artery segments grafted into eGFPapoE/ mice. Concordantly, 96% of SMCs were eGFP in
plaques induced in eGFPapoE/ artery segments grafted into apoE/ mice.
Conclusions—These experiments show that SMCs in atherosclerotic plaques are exclusively derived from the local vessel
wall in apoE/ mice. (Arterioscler Thromb Vasc Biol. 2006;26:2696-2702.)
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Recruitment of smooth muscle cells (SMCs) is a keymechanism in the development of atherosclerosis and its
clinical manifestations. SMCs contribute to plaque volume
through matrix synthesis, and the accretion of SMCs plays a
decisive role in the pathogenesis of coronary stenosis.1
Conversely, paucity of SMCs in the fibrous cap of plaques
increases the risk of plaque rupture and life-threatening
arterial thrombosis.2 Understanding the origin of plaque
SMCs may provide new opportunities for controlling their
ambiguous nature.
See page 2579 and cover
Until recently, the only source of SMCs in atherosclerotic
lesions was considered to be the local vessel wall. According
to this hypothesis, local SMCs in the arterial media and
intima modulate into a synthetic and migratory phenotype
(aka, phenotypic modulation3) and form the fibrous compo-
nent of the plaque. This theory was essentially inferred from
a line of suggestive observations in arterial injury models in
the 70s and 80s.4,5 More to the point, Cre/lox fate mapping in
the apoE knockout (apoE/) mouse model of atherosclerosis
recently confirmed that preexisting SMCs, presumably from
the local media, contribute to plaque SMCs during athero-
genesis, but the existence of other sources could not be
excluded by this technique.6
In 2002, an alternative and major source of SMCs in
atherosclerosis was reported,7 and this new paradigm has
great impact on current research in this area.8,9 Based on
observations in bone marrow (BM)-transplanted apoE/
mice, it was concluded that a substantial fraction of plaque
SMCs arise from circulating progenitor cells of hematopoi-
etic origin.7 This pathway holds promise for the development
of novel therapeutic means of controlling the recruitment and
accumulation of SMCs in plaques. However, it remains
questionable whether the quality of the histological documen-
tation in that study can support a definitive conclusion,
especially because the seeming use of unfixed tissue for
detection of enhanced green fluorescent protein (eGFP) can
lead to diffusion of the tracer marker from sectioned cells.10
Furthermore, reconstitution of apoE/ mice with apoE/
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BM as performed in that experiment provides powerful
protection against the development of atherosclerosis.11
To address these concerns, we repeated the BM transplan-
tation experiment in apoE/ mice with a number of method-
ological modifications but could not replicate the results. To
confirm and extend these findings, we then studied athero-
sclerosis induced in surgically transferred arterial segments.
Here, we show that atherosclerotic plaque SMCs are derived
from the local vessel wall and not circulating smooth muscle
progenitor cells in apoE/ mice.
Methods
For a detailed Methods section, please see the online data supple-
ment, available online at http://atvb.ahajournals.org.
Transgenic Animals
The Danish Animal Experiments Inspectorate approved all proce-
dures. ApoE/ mice (B6.129P2-Apoetm1Unc; Taconic M&B, Ry,
Denmark), backcrossed more than 10 times to C57BL/6 mice, and
eGFP C57BL/6 mice (C57BL/6-Tg[ACTB-EGFP]1Osb/J; Jackson
Laboratories, Bar Harbor, Me), were intercrossed to obtain
eGFPapoE/ mice (hemizygous for the eGFP transgene).
Bone Marrow Transplants
ApoE/ mice (n28) were lethally irradiated and rescued with
sex-matched bone marrow from eGFPapoE/ mice as previously
described (Figure 1a).12 Age-matched apoE/ (n8) and
eGFPapoE/ mice (n8) were included as controls. One mouse
died shortly after BM transplantation. Four randomly-chosen BM-
transplanted mice were killed after 4 weeks. The other mice were
changed from chow to high fat diet (21% saturated fat, 1.5%
cholesterol, Hope Farms, Woerden, Netherlands) to accelerate
atherogenesis and then killed at 20 or 32 weeks of age.
Atherosclerosis Induced in Transplanted
Arterial Segments
We performed orthotopic transplantations of common carotid artery
(CCA) segments between eGFPapoE/ and apoE/ mice
(eGFPapoE/ CCA 3 apoE/ transplanted mice, n12, and
apoE/ CCA3 eGFPapoE/ transplanted mice, n12, excluding
perioperative deaths). Transplantations were isogenic apart from the
eGFP transgene and immunogenicity of eGFP has been reported to
be minimal in the background C57BL/6 strain.13
All grafted vessels were patent after 6 weeks. Then, localized
atherosclerosis was induced by placement of a constrictive perivas-
cular collar around the distal part of the graft using a technique
slightly modified from von der Thu¨sen et al (n10 from each group)
(Figure 1b).14 Four mice (eGFPapoE/ CCA 3 apoE/ trans-
planted mice, n2, and apoE/ CCA3 eGFPapoE/ transplanted
mice, n2) were treated identically with the exception that no collars
were inserted.
Immunohistochemistry
SMCs were identified by staining for smooth muscle -actin
(SMA). This abundant protein is considered the most sensitive,
though not specific, SMC marker. SMA is expressed early in
embryonic development15 and lost late in phenotypic modulation,3
and it is the marker on which previous conclusions on BM origin of
plaque SMCs have been based.7,16 Specificity of SMA stainings
was confirmed by observing the expected subplasmalemmal distri-
bution of SMA in plaque SMCs and by negative isotype control
stainings. The Mac2 epitope was used as a marker for
plaque macrophages.
Fluorescence In Situ Hybridization
The Y chromosome was visualized in a subset of SMA stained
aortic root sections. First, z-axis image stacks of SMA cell-
containing areas were acquired and stored. Then, cover slips were
removed and the immunostained sections were pretreated in
10 mmol/L sodium citrate, pH 6.0 (2 hours, 80°C) and 0.025%
pepsin solution (10 minutes, 37°C; Sigma), which totally extin-
guished eGFP fluorescence and deteriorated the SMA staining
signal. Y chromosomes were then detected by a fluorescein isothio-
cyanate (FITC)-conjugated paint probe using the protocol recom-
mended by the manufacturer (Cambio), and the phenotype of cells
with Y nuclei was identified in the stored images. This sequential
technique allows for a robust analysis, because the cell phenotype is
analyzed before the harsh pretreatment necessary for fluorescence in
situ hybridization (FISH) distorts morphology.
Microscopic Analysis
Sections were examined in an Olympus Cell-R epifluorescence
microscope system equipped with differential interference contrast
(DIC) optics and motorized focus. Deconvolution analysis on wide-
field z-axis image stacks (0.3 m optical thickness) was performed
in a subset of sections (aortic root sections for sequential FISH
analysis and CCA plaques) by using a blind 3D deconvolution
algorithm (Autoquant Deblur 9.3; Autoquant Imaging). This tech-
Figure 1. Overview of experimental design and results. a, Analysis of sex-mismatched eGFPapoE/ BM 3 apoE/ transplanted mice
using eGFP or Y chromosome as tracers. *Per total number of SMA profiles analyzed. †Per total number of nucleated SMA profiles
analyzed. BMT indicates bone marrow transplantation; HF, high-fat diet; AR, aortic root; AA, aortic arch; BT, brachiocephalic trunk;
AbA, Abdominal aorta; ThA, descending thoracic aorta. b, Analysis of atherosclerotic plaques induced in transplanted CCA segments.
CCAT indicates common carotid artery segment transplantation. See text for description of additional control experiments.
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nique, like confocal microscopy, yields high signal-to-noise images
of thin optical sections.
SMA cell profiles in the range of small SMC nuclei or larger
(from 3 m [minor axis]  5 m [major axis]) were analyzed for
colocalization. Because all SMCs contain a nucleus of relatively
similar size, this strategy is an accurate analysis of the presence of
eGFP SMA cells and avoids many interpretational problems
presented by smaller autofluorescent structures and overlapping parts
of closely opposed eGFP and SMA cells. The number of
analyzed SMA profiles was counted to estimate statistical power.
In BM transplanted mice, we estimated the total number by counting
a representative subset (34%) of the sections. Nucleated SMA
profiles, defined as cells where the nucleus were circumscribed by
SMA stain, were counted and analyzed for combined Y chromo-
some and SMA signal.
Statistical Analysis
Rare binomially distributed events approach the Poisson distribution,
and a 95% confidence limit for double-positive cells were calculated
by this approximation (95% confidence limit: P3.0/number of
observations). Sections were taken at least 50 m apart to ensure that
the same SMC was not analyzed twice.
Results
Sex-Mismatched BM Transplantation
The degree of hematopoietic chimerism obtained in
eGFPapoE/ BM 3 apoE/ transplanted mice was as-
sessed by flow cytometry of peripheral blood leukocytes. The
fraction of fluorescent cells in BM transplanted mice 4 and 24
weeks after transplantation was 93.42.8% (meanSD,
n23) and 93.71.4% (n12), respectively, which was
similar to that of eGFPapoE/ positive control mice
(92.42.0% [n4] and 92.20.8% [n4], respectively;
Figure 2a). The sustained presence of eGFP leukocytes
documents the replacement of hematopoietic stem cells,
which are the only long-term self-renewing cells in the
hematopoietic system.17 Plasma lipid values are described in
supplemental Table I.
Vascular Pathology in BM Chimeras
In animals euthanized 4 weeks after BM transplantation
(n4), only foam cell lesions were present at the arterial sites
selected for analysis, excluding the possibility that SMCs had
entered the intima already before full reconstitution of the
hematopoietic system with eGFP cells was confirmed. At 20
weeks of age, all mice had developed fibrofatty plaques in the
aortic root, and fibrofatty plaques were also present in the
aortic arch, brachiocephalic trunk, abdominal aorta, and to a
variable extent in the descending thoracic aorta at 32 weeks of
age.
Atherosclerotic Plaque SMCs Are Not Derived
From Hematopoietic Stem Cells
As an internal validation of the experiment, the hematopoietic
origin of plaque macrophages was verified by the demonstra-
tion of cells double-positive for eGFP and the murine
macrophage marker Mac2 in plaques in BM transplanted
mice (Figure 2b).
SMA cells were predominantly located in the fibrous
cap separating the core of the plaque from the arterial lumen.
As expected, SMA cells were almost uniformly eGFP in
eGFPapoE/ positive control mice (n4, 32 weeks of age,
580 of 598 SMA cell profiles analyzed). In agreement with
observations reported by others, SMA expression was lost
in major parts of the media underlying atherosclerotic plaques
(Figure 3).7
We did not identify a single eGFPSMA cell among
10 000 SMA cell profiles analyzed in 154 sections from
multiple sites of the arterial tree in 23 BM-transplanted mice
(95% confidence limit 0.03%) (Figures 1a and Figure 3;
supplemental Figure I). The identical result was reached
using blind 3D deconvolution performed on a subset of the
same sections from the aortic root (Figure 4).
As an independent tracing method, we detected Y chromo-
somes in SMA immunostained sections from the aortic root
(Figure 4). Not once did we convincingly detect a Y chro-
mosome in 367 analyzed nucleated SMA profiles in
plaques from male-to-female BM-transplanted mice. In one
inconclusive case, a SMA profile circumscribed two nu-
clear profiles, one of which was Y chromosome. A positive
Y chromosome signal was detected in 114 of 209 analyzed
nucleated SMA cell profiles (54%) in female-to-male
BM-transplanted mice, which was similar to that detected in
Figure 2. The hematopoietic system in irradi-
ated apoE/ mice was reconstituted with
eGFPapoE/ cells after BM transplanta-
tion. a, Flow cytometry of peripheral blood
leukocytes. Left panel, Cells within a defined
forward-side scatter gate that encompassed
the major leukocyte populations were ana-
lyzed. Right panel, Green fluorescence of
leukocytes obtained from an apoE/ mouse
(top), an eGFPapoE/ mouse (middle), and
an eGFPapoE/ BM3 apoE/ trans-
planted mouse (bottom). b, Macrophage
foam cells detected by the murine macro-
phage marker Mac2 were eGFP in BM
transplanted mice as expected. Aortic root
plaque from eGFPapoE/ BM3 apoE/
transplanted mouse (32 weeks of age).
Green indicates eGFP; Red, Mac2; Yellow,
overlay of eGFP and Mac2; Blue, DAPI; Gray
scale, DIC. Color channels are shown sepa-
rately to facilitate interpretation. L indicates
lumen; F, foam cells; M, tunica media. Scale
bar100 m.
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plaques from the control apoE/ and eGFPapoE/ male
mice (n22, 32 weeks of age, 48 of 94 analyzed nucleated
SMA cells) and in the range predicted from the thickness
of the section and the nuclear size.
SMCs Are Derived From the Local Vessel Wall in
Cross-Grafted Arterial Segments
Our observations in BM-transplanted mice showed that dif-
ferentiation of hematopoietic stem cells to plaque SMCs is
exceedingly rare if it occurs at all. To evaluate whether
circulating smooth muscle progenitor cells of nonhematopoi-
etic origin can contribute to atherosclerotic plaque SMCs, we
then analyzed SMC origin in atherosclerotic lesions that were
induced proximal to a constrictive collar in cross-grafted
CCA segments (Figures 1b and 5a).
Of 20 mice in which we performed CCA segment trans-
plantations and collar placements, complete or near-complete
graft occlusions were present in 5 mice at time of sacrifice. In
4 mice, no significant lesions were found, and in 2 mice,
extensive lesion formation extending into the graft from the
proximal anastomosis was present. These were all excluded
from the analysis. Most likely, the cause of these technical
failures was inconsistency in tightening of the ligature around
the collar to yield appropriate constriction. None of the
CCA-transplanted mice in which no collar was placed devel-
oped lesions in the grafted artery apart from a small mural
thrombus in one.
In all other mice, advanced plaques had developed focally
immediately proximal to the constrictive collar with an area
of unaffected vessel wall separating the lesion from the
proximal anastomosis site (Figure 5b). In plaques that had
formed in apoE/ artery segments grafted into
eGFPapoE/ mice (n4), not a single eGFPSMA cell
Figure 3. Hematopoietic stem cells do not contrib-
ute to plaque SMCs. a, Overview of aortic root
plaque from eGFPapoE/ BM 3 apoE/ trans-
planted mouse (32 weeks of age) exhibiting donor-
derived eGFP foam cells (green) and the forma-
tion of a fibrous cap of recipient-derived SMA
cells (red only). L indicates lumen; C, fibrous cap;
F, foam cells; M, tunica media; A, tunica adventitia.
Scale bar200 m. b, Higher magnification of the
area demarcated in a. Fluorescence microscopy
combined with DIC imaging (gray scale) to reveal
tissue structure. Scale bar50 m. c-e, Further
analysis of the area demarcated in b. With the
superimposed DIC image, it is often possible to
visualize cell boundaries that would otherwise
escape detection by fluorescence microscopy.
Arrows indicate two separate cellular structures
appearing as depressions in the relief-like DIC
image (c), one of which stains positive for SMA
(d, red channel). The neighboring cell is eGFP (e,
red and green channels). No eGFP SMA
double-positive cells are present. Scale
bar25 m.
Figure 4. Sequential immunostaining and FISH
technique revealed no male SMA cells in
plaques in male eGFPapoE/ BM 3 female
apoE/ transplanted mice. The figure shows anal-
ysis of an aortic root plaque from a mouse 20
weeks of age. a, SMA immunostained sections
were analyzed and the digitized images were
stored. Deconvoluted optical section is shown.
Arrows indicate nuclei that proved to contain a Y
chromosome with subsequent FISH. Red indicates
SMA; Green, eGFP; Blue, DAPI. Scale
bar50 m. b, FISH for Y chromosome. Fluores-
cence of eGFP is completely extinguished by the
FISH procedure, and only the green fluorescence
resulting from the FITC-conjugated Y chromosome
paint probe is visible. Deteriorated SMA staining
(red channel) is not shown. The phenotype of cells
with Y nuclei is identified by comparing with the
stored image (a). c-e, Larger magnifications of a
and b. Scale bar25 m. F indicates foam cells;
C, Fibrous cap; L, lumen.
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was detected in 54 serial sections (10 to 16 per plaque),
encompassing 684 SMC profiles (95% confidence limit,
0.4%; Figure 6a through 6c). Concordantly, in plaques
induced in eGFPapoE/ artery segments grafted into
apoE/ recipients (n5), nearly all SMA cells were
eGFP (Figure 6d through 6f). We analyzed 34 sections from
this type of lesion (6 to 9 per plaque) and found that 469 of
487 (96%) SMC profiles were clearly eGFP, which was
similar to that seen in plaques from positive control
eGFPapoE/ mice.
Discussion
In this study, we traced the origin of plaque SMCs in different
models of atherosclerosis in the apoE/ hyperlipidemic
mouse. First, we attempted and failed to reproduce the
previous finding that hematopoietic stem cells can contribute
to plaque SMCs in BM chimeric apoE/ mice.7 Second, we
directly evaluated and confirmed that plaque SMCs are
derived from cells of the local vessel wall in a novel model of
collar-induced atherosclerosis in surgically transferred artery
segments.
Induction of Atherosclerosis in Surgically
Transferred CCA Segments
An important premise for basing our conclusions on the
collar-induced atherosclerosis model is that the pathogenesis
is equivalent to that of spontaneously developing atheroscle-
rosis. An extensive number of observations support this
assumption. Lesions in the constrictive collar model develop
immediately proximal to the collar, presumably elicited by
low wall shear stress in this region,18 and are strictly
dependent on the presence of hypercholesterolemia.14 Thus,
lesion development in this model appears to depend on the
two key etiologic factors known for spontaneous atheroscle-
rosis. These features distinguish the constrictive collar model
fundamentally from any other mechanical means of inducing
intimal lesions, including the classic loose cuff model of
neointima formation.19 Furthermore, constrictive collar-
induced lesions are pathoanatomically reminiscent of spon-
taneously developing atherosclerosis with respect to the
presence of macrophage foam cells (supplemental Figure II),
cholesterol crystals, fibrous caps, and necrotic cores (Figure
6d). It can never be proved that constrictive collar-induced
and spontaneous atherosclerosis are identical pathological
entities, but it seems unlikely that disease processes that
resemble each other to such detail in etiology and morphol-
ogy would differ in a key mechanism such as SMC
recruitment.
Origin of SMCs in Different Vascular
Disease Models
The present study is only one of several recent studies to have
(re)investigated the origin of lesional SMCs in arterial dis-
ease, and not the first to have reached a conclusion that
conflicts with others. Surprisingly few groups have examined
the most prevalent arterial disease, atherosclerosis,7,16 but
analogous investigations have been carried out in a number of
other vascular disease models.8,9
The major discussion stemming from these studies has
been over the question whether lesional SMCs can originate
from BM cells. Besides the report of Sata et al on atheroscle-
rosis in apoE/ mice,7 this has been described to occur in
human atherosclerosis,16 and in rodent models of wire inju-
ry,7,20 ferric chloride injury,21 and allotransplantation arteri-
opathy.7,22 Others, however, have not been able to detect
BM-derived SMCs in allotransplantation arteriopathy,12 and
it has been reported not to be involved in the pathogenesis of
vein graft atherosclerosis,23 ligation-induced neointima,19 and
neointima formed within a loose cuff.19
It is conceivable that part of the disparity in these findings,
including the conflict between our results and those of Sata et
al,7 is attributable to methodological or interpretational dif-
ferences. For instance, it is strikingly difficult, despite a
considerable literature, to find compelling images of BM-
derived SMA cells with the expected SMC morphology.
But it is also reasonable to think that biological differences
between models are important. Even though intimal SMC
accumulation is the common hallmark of many types of
vascular disease, the etiology and pathogenesis of lesion
development differ. Interestingly, recruitment of circulating
smooth muscle progenitor cells has predominantly been
reported in models with significant endothelial disruption and
platelet deposition, and experimental evidence indicates that
SDF expressed by adhering platelets facilitates homing of
circulating progenitor cells.24 This hypothesis offers a possi-
ble explanation for the discrepancy between our results and
those reported for coronary atherosclerosis in sex-
mismatched BM transplanted patients.16 It is possible that
asymptomatic plaque rupture with mural thrombus in hu-
mans, which is not seen in the mouse model, is critical in
mediating homing of circulating progenitor cells.
Figure 5. Schematic of the model of constrictive collar-induced
atherosclerosis in surgically transferred CCA segments. First,
the graft was interpositioned in the recipient CCA by two end-
to-end anastomoses. Then after 6 weeks, a slightly constrictive
piece of silicone tubing was positioned around the distal part of
the graft, and this induced the formation of an atherosclerotic
plaque in the grafted CCA immediately proximal to the collar in
the course of 10 weeks. b, Atherosclerotic plaque in the trans-
planted CCA 10 weeks after collar insertion. PA indicates proxi-
mal anastomosis; C, Collar; DA, distal anastomosis; P, plaque.
Scale bar1 mm.
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The finding of intimal SMCs that do not originate from the
graft or from hematopoietic stem cells in rodent models of
vein graft atherosclerosis and allotransplantation arteriopathy
has led to the theory that circulating smooth muscle progen-
itor cells of nonhematopoietic origin exist and participate in
vascular lesion formation.25 It is, however, important to
realize that migration of SMCs from the contiguous vascula-
ture into the graft in those types of studies has not been
conclusively excluded. For instance, Hu et al found that 40%
of SMCs in atherosclerotic lesions of vein grafts were not
derived from the local vessel wall or from hematopoietic stem
cells, but the experimental design did not allow to distinguish
between SMCs migrating through the anastomosis sites and
homing and differentiation of SMCs from nonhematopoietic
circulating progenitor cells.23 If migrating medial SMCs were
the source of these cells, then the fact that our lesions
developed isolated from the recipient vasculature by a stretch
of unaffected donor vessel (Figure 6a), whereas lesions in the
vein graft model did not, may explain the differences in the
result obtained. Another explanation could be the inherent
differences between SMCs of arterial and venous origin.26
Local Source of Plaque SMCs
Our experiments were not designed to discriminate between
candidate sources for plaque SMCs within the vascular wall.
Several alternatives to vascular SMCs have been proposed,
including endothelial-to-SMC differentiation and invasion of
fibroblasts or stem cell progeny from the tunica adventi-
tia.27,28 However, the identification of the local arterial wall as
the origin of plaque SMCs established in this study combined
with the observation of Feil et al that a major fraction of
plaque SMCs originate from SM22 cells,6 pinpoint that in
mice—that have no resident intimal SMCs—tunica media is
the major contributor to SMCs in atherosclerotic plaques.
Conclusions
Our experiments demonstrate that atherosclerotic plaque
SMCs are derived exclusively from the local vessel wall in
apoE/ mice. This observation strongly supports the original
hypothesis that these cells originate from local vascular
SMCs and disagrees with the proposed role of circulating
smooth muscle progenitor cells in atherogenesis. These find-
ings have implications for future research into the mecha-
nisms by which the fibrous component of atherosclerosis
develops.
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Figure 6. Analysis of atherosclerotic
plaques induced in surgically transferred
CCA segments demonstrated that
plaque SMC are derived from the local
arterial wall. a-c, All SMA cells were
eGFP- in plaques developing in apoE/
CCA segments grafted into
eGFPapoE/ mice. The eGFP signal
visible in the top left corner of a is an
artifact caused by diffusion into the outer
medial layer of perivascular extracellular
eGFP, which was abundantly present
around transplanted vessels in
eGFPapoE/ mice. Red indicates
SMA; green, eGFP; blue, DAPI; gray-
scale, DIC; L, lumen; C, fibrous cap; F,
foam cells; M, tunica media. Scale
bar25 m. d-e, Conversely, in plaques
induced in eGFPapoE/ CCA seg-
ments grafted into apoE/ mice, virtually
all SMA cells were eGFP. L indicates
lumen; C, fibrous cap; NC, necrotic core;
F, foam cells; M, tunica media. Scale
bar25 m.
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Supplementary Methods 
Transgenic mice 
ApoE-/- mice (Taconic M&B, Ry, Denmark) and eGFP+ mice (Jackson Laboratories, Bar Harbor, 
ME), both backcrossed more than ten times to C57BL/6 mice, were intercrossed to obtain 
eGFP+apoE-/- mice (hemizygous for the eGFP transgene).1,2 Genotyping for apoE was performed 
using primers recommended by the Jackson Laboratory (5-GCCTAGCCGAGGGAGAGCCG-3, 5-
TGTGACTTGGGAGCTCTGCAGC-3, and 5-GCCGCCCCGACTGCATCT-3). Phenotyping for 
eGFP was done using a Woods UV lamp.  
 
Bone marrow transplantations 
Crude bone marrow was flushed from femurs and tibias from eGFP+apoE-/- mice 8 weeks of age 
(n=7). Cells were washed twice in RPMI-1640 (Invitrogen) and filtered through a 70 μm mesh. 
ApoE-/- mice (n=28) 8 weeks of age were irradiated with 10 Gy from a 137Cs source and 107 
unfractionated bone marrow cells were injected into a tail vein 4 hours later. Mice were housed with 
filter tops and administered oxytetracyclin (2g/l Terramycin vet. 20%) one day prior to and 7 days 
after transplantation.  
  
Flow cytometry  
Blood (50 μl) was lysed in erythrocyte lysis buffer (NH4Cl 8.02 g/L, NaHCO3 0.84 g/l, Na2EDTA 
0.37 g/l). The fraction of green fluorescent leukocytes in peripheral blood was measured in a 
forward-side scatter gate that was enriched for CD45+ cells (>98%) and excluded only a few CD45+ 
cells (~2%) as established in pilot experiments.  
 
 
Plasma lipids analysis  
Plasma total cholesterol and triglycerides were measured on a Vitros 950 analyzer (Ortho-Clinical 
Diagnostics). HDL cholesterol (HDL-C) was measured enzymatically on a Kone 30 analyzer 
(Thermo) using kits from ABX (Triolab, Copenhagen, Denmark).  
 
Common carotid artery segment transplantation and collar placement  
Donor common carotid arteries (CCA) were flushed with 100 IU/ml heparin saline and kept in 
RPMI-1640 at room temperature. Recipient mice were anesthetized with isoflurane (induction 5%, 
maintenance 1.5%-2%) and the right CCA was accessed through a midline neck incision. Heparin 
was administered (200 IU/kg i.m.) before microvascular clamps were applied. The recipient CCA 
was then divided and the donor CCA segment was interposed by two end-to-end anastomoses of 
four symmetrically placed 11-0 polyamide single sutures (Ethicon, Johnson & Johnson, Birkerød, 
Denmark). Total operation time was 75-90 minutes. Perioperative mortality was 15 per cent. 
Postoperative analgetics (buprenorphine, 0.1 mg/kg s.c. repeated every 12 hours for 3 days) were 
administered. An instructional video of the procedure can be obtained from the corresponding 
author. 
Six weeks after CCA transplantation, mice were reoperated under isoflurane anesthesia and collars 
made from 0.75 mm silicone tubing (inner diameter 0.31 mm, HelixMark, Helix Medical Inc., CA, 
USA) were positioned around the most distal segment of the graft and secured by a single 7-0 
ligature. 
 
Tissue processing  
Anesthetized mice (pentobarbital 5 mg i.p.) were killed by exsanguination, pressure-fixed with a 
phosphate-buffered (pH 7.2) formaldehyde solution (4%) through the left ventricle for 5 minutes, 
and immersion-fixed for 6 hours at room temperature. The aortic root, aortic arch, right CCA, 
brachiocephalic trunk, abdominal aorta and descending thoracic aortas were removed, cryoprotected 
in a sucrose solution (25 % w/v for 24 h + 50 % w/v for 24 h), embedded in O.C.TTM compound 
(Sakura Finetek, Pro-Hosp, Vaerloese, Denmark), and snap-frozen in liquid nitrogen-chilled 
methanol:acetone (1:1). Specimens were sectioned at 4-5 μm thickness.   
 
Immunohistochemistry 
SMCs were identified by staining for smooth muscle α-actin (SMαA) using biotinylated mouse 
monoclonal anti-SMαA (1:50, Clone 1A4, Neomarkers MS-113-B, AH Diagnostics, Aarhus, 
Denmark) followed by Alexa 594-conjugated streptavidin (1:200, Molecular Probes, Invitrogen, 
Taastrup, Denmark). Endogenous biotin was blocked with an avidin-biotin blocking kit (Vector 
Labs, VWR, Albertslund, Denmark) and a biotinylated irrelevant monoclonal antibody (1:50, 
Neomarkers NC-1390-B) of the same isotype was used as negative control. We would expect our 
two-layer immunofluorescence technique to be at least as sensitive as the one-layer method used by 
Sata et al.3 To further ensure sufficient sensitivity of our staining procedure, we initially compared 
this method to SMαA staining visualized by high-sensitive tyramide signal amplification (TSATM 
Biotin System, Perkin Elmer, Hvidovre, Denmark), and found that both techniques gave similar 
results in terms of number of SMαA+ cells identified (data not shown).  
The Mac2 epitope was stained as a marker for plaque macrophages by using rat anti-mouse Mac2 
antibody (1:500, CL8942AP, Cedarlane Labs, Trichem Aps, Frederikssund, Denmark) followed by 
Texas Red-conjugated goat anti-rat secondary antibody (1:200, Jackson Immunoresearch, 
Cambridgeshire, UK). An irrelevant rat monoclonal antibody (1:50, R2a00, Caltag, Trichem) was 
used as negative control.  
 
Fluorescence in situ hybridization (FISH) 
The Y chromosome was visualized in sections by a FITC-conjugated chromosome paint probe 
(Cambio, Cambridge, UK). Sections were first immunostained for SMαA, and high-power fields of 
SMαA+ cells were photographed. Then, the cover slips were removed and the sections were 
pretreated in 10 mM sodium citrate, pH 6.0 (2h, 80°C) (Bie & Berntsen, Aarhus, Denmark), 
digested in pepsin solution (0.025%, 10 min, 37 °C, Sigma), fixed in 4% paraformaldehyde and 
treated in freshly prepared acetic acid (0.25% acetic anhydride in 0.1 M triethanolamine-HCl, pH 
8.0, 10 min, room temperature (Sigma)) to reduce unspecific binding of the probe. Two μl paint 
probe was applied to dehydrated sections under cover slips, and probe and tissue were denatured at 
60 °C for 10 min followed by overnight hybridization at 37 °C. Slides were washed in 50% 
formamide/1xSSC (15 min, 37°C) and in 2xSSC (15 min, 37°C), before incubation in DAPI 
solution and mounting in Slowfade Light Antifade.  
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Supplementary Table I. Plasma lipids in bone marrow transplanted mice at sacrifice 
 Total cholesterol 
mmol/L 
HDL cholesterol 
mmol/L 
Triglycerides 
mmol/L 
20 weeks of age 
(n=11)*
20.3±6.6 0.43±0.26  0.81±0.26 
32 weeks of age 
(n=12)†
11.7±1.6 0.31±0.18 0.79±0.31 
*On high fat diet. †On chow diet. 
Supplementary Figure I 
 
 
 
 
Supplementary Figure I. Not a single plaque SMC derived from donor bone marrow cells 
administered at bone marrow transplantation was found. Two high power fields of an aortic root 
plaque from an eGFP+apoE-/- BM → apoE-/- transplanted mouse (32 weeks of age) are shown.  All 
SMαA+ cells are eGFP+. Color channels are shown separately [SMαA in (a,d), eGFP in (b,e) and 
combined (c,f)] to facilitate interpretation. L. Lumen. C. Fibrous cap. F. Foam cells. M. Tunica 
media. Red, SMαA. Green, eGFP. Greyscale, differential interference contrast. Scale bar 50 μm.  
 
Supplementary Figure II 
 
 
 
Supplementary Figure II. Collar-induced atherosclerosis in transplanted common carotid artery 
(CCA) segments is pathoanatomically reminiscent of spontaneously developed atherosclerosis in 
apoE-/- mice. In this figure the occurrence of foam cells is shown in an eGFP+ apoE-/- CCA graft 
anastomosed into an apoE-/- recipient mouse. As expected, foam cells in the plaque are derived from 
the circulation (eGFP-) and positive for the macrophage marker Mac2. Red, Mac2. Green, eGFP. L, 
lumen, C. fibrous cap. F, foam cells. Scale bar 50 μm. 
 
 
 
